Recent Advances in Pharmaceutical Innovation and Research
暫譯: 藥物創新與研究的最新進展

Professor (Dr.) Prati Pal Singh, an internationally renowned educationist, scientist, and science writer/editor/communicator formerly worked at the National Institute of Pharmaceutical Education and Research (NIPER), S. A. S Nagar, India. For his Ph. D. degree (1980), he worked at the Central Drug Research Institute, Lucknow, and did postdoctoral research at Stanford University Medical Centre, CA, USA (1986), and The Ohio State University, OH, USA (1984-85). Prof. Singh has been a visiting fellow at the Montreal General Hospital, Montreal, Canada (1985). He is an eminent biotechnologist, parasitologist, microbiologist, immunologist, and neuroimmunopharmacologist. Prof. Singh has worked extensively on the pre-clinical and clinical development of satranidazole, a new anti-amoebic drug now on the market. He first reported opiates as a new class of drugs for the treatment of parasitic/microbial infections and has made seminal contributions to the treatment of malaria, tuberculosis, leishmaniasis, amoebiasis, and trichomoniasis. Prof. Singh has edited/co-edited four books. He has over 200 research publications including one in Nature Medicine, five editorials, and nine patents including one US patent to his credit, and 81 Ph. D. and Master's degrees have been awarded under his guidance. Prof. Singh has been the Editor-in-Chief of the Journal of Parasitic Diseases and is on the Editorial Board of the Journal of Neuroimmune Pharmacology and several other international journals. Prof. Singh has been elected Fellow of The National Academy of Sciences, India (2004) and Fellow of the Indian Academy of Microbiological Sciences (2008), and was nominated for the fellowships of the Indian National Science Academy and the Indian Science Academy. He was elected At-Large Councillor (non-US), Society on Neuroimmune Pharmacology USA in 2010. Prof. Singh has been awarded prestigious the Bill and Melinda Gates Foundation Global Health Award in 2008, the National Institute on Drug Abuse, USA award in 2006, and the Tulasbai Somani Educational Trust Award of the Indian Academy of Neurosciences in 1992. Prof. Singh has been one of the Principal Investigators of the Indo-European Union 7th Framework Programme (2008) collaborative project "New Approaches to Target Tuberculosis". He has been invited to several lectures/official meetings both in India and in the USA, the U. K., Canada, Switzerland, France, Germany, Austria, Italy, Belgium, and China. He has been the Nodal Officer of NIPER, Raebareli, and Member/Chairman of several high-powered Scientific Advisory Committees/sub-committees, various award committees, and selection committees of several institutes. Prof. Singh has been a Senator and Associate Dean (Academic Affairs) of NIPER.

普拉提·帕爾·辛格教授（博士）是一位國際知名的教育家、科學家及科學作家/編輯/傳播者，曾在印度S. A. S Nagar的國家藥物教育與研究所（NIPER）工作。他於1980年獲得博士學位，研究於中央藥物研究所（Central Drug Research Institute），位於印度勒克瑙，並於1984至1985年在美國俄亥俄州立大學（The Ohio State University）進行博士後研究，1986年在美國斯坦福大學醫學中心（Stanford University Medical Centre）進行研究。辛格教授曾擔任加拿大蒙特利爾總醫院的訪問研究員（1985年）。他是一位傑出的生物技術專家、寄生蟲學家、微生物學家、免疫學家及神經免疫藥理學家。辛格教授在新型抗阿米巴藥物satranidazole的臨床前及臨床開發方面有廣泛的研究。他首次報導了鴉片類藥物作為治療寄生蟲/微生物感染的新藥物類別，並對治療瘧疾、結核病、利什曼病、阿米巴病及陰道滴蟲病做出了開創性的貢獻。辛格教授編輯或共同編輯了四本書籍，擁有超過200篇研究出版物，包括一篇發表於《Nature Medicine》的文章、五篇社論及九項專利，其中包括一項美國專利，並在他的指導下頒發了81個博士及碩士學位。辛格教授曾擔任《寄生蟲疾病期刊》（Journal of Parasitic Diseases）的主編，並在《神經免疫藥理學期刊》（Journal of Neuroimmune Pharmacology）及其他幾本國際期刊的編輯委員會中任職。辛格教授於2004年當選為印度科學院（The National Academy of Sciences, India）院士，2008年當選為印度微生物科學院（Indian Academy of Microbiological Sciences）院士，並被提名為印度國家科學院及印度科學院的院士。他於2010年當選為美國神經免疫藥理學會（Society on Neuroimmune Pharmacology USA）的非美國區域理事。辛格教授於2008年獲得比爾和梅琳達·蓋茨基金會全球健康獎，2006年獲得美國國家藥物濫用研究所獎，1992年獲得印度神經科學院的Tulasbai Somani教育信託獎。辛格教授是印歐聯盟第七框架計畫（2008）合作項目「針對結核病的新方法」的主要研究者之一。他受邀在印度及美國、英國、加拿大、瑞士、法國、德國、奧地利、意大利、比利時及中國進行多場講座及官方會議。他曾擔任NIPER Raebareli的聯絡官，並是多個高層科學諮詢委員會/子委員會、各種獎項委員會及多個機構的選拔委員會的成員/主席。辛格教授曾擔任NIPER的參議員及副院長（學術事務）。